DEVELOPMENTAL HIP DYSPLASIA

This adverse event was reported 832 times

DEVELOPMENTAL HIP DYSPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BUTOCONAZOLE NITRATE 1 0.2000
1 VELMANASE ALFA-TYCV 1 0.0179
2 MEPIVACAINE HYDROCHLORIDE 9 0.0078
3 ELOSULFASE ALFA 24 0.0044
4 GALSULFASE 16 0.0041
5 PROPYLTHIOURACIL 8 0.0038
6 PANTHENOL 1 0.0034
7 METHYLERGONOVINE MALEATE 2 0.0033
8 ONASEMNOGENE ABEPARVOVEC-XIOI 7 0.0030
9 ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL 1 0.0028
See all drugs enriched for association with DEVELOPMENTAL HIP DYSPLASIA